Table 3

Procedural Characteristics

Overall (N = 1,116)Normal RV Function (n = 791)RV Dysfunction (n = 325)p Value
Procedural characteristics
 Procedure time, min68.1 ± 33.668.0 ± 34.568.1 ± 31.20.96
 Length of hospital stay, days9.0 ± 4.48.7 ± 4.19.8 ± 5.10.001
 General anesthesia340 (30.5)227 (28.7)113 (34.8)0.053
Access route0.40
 Femoral951 (85.2)682 (86.2)269 (82.8)0.16
 Apical151 (13.5)101 (12.8)50 (15.4)0.25
 Subclavian11 (1.0)6 (0.8)5 (1.5)0.31
 Other3 (0.3)2 (0.3)1 (0.3)1.00
Type of valve0.06
 CoreValve (Medtronic, Minneapolis, Minnesota)393 (35.3)257 (32.5)136 (42.0)0.003
 Sapien XT (Edwards, Irvine, California)319 (28.6)229 (29.0)90 (27.8)0.72
 ACURATE (Symetis, Ecublens, Switzerland)43 (3.9)31 (3.9)12 (3.7)1.00
 Portico (St. Jude Medical, Minneapolis, Minnesota)7 (0.6)6 (0.8)1 (0.3)0.68
 Sapien 3 (Edwards)222 (19.9)165 (20.9)57 (17.6)0.22
 Lotus (Boston Scientific, Natick, Massachusetts)67 (6.0)51 (6.5)16 (4.9)0.41
 Evolut R (Medtronic)63 (5.7)51 (6.5)12 (3.7)0.09
Revascularization
 Concomitant PCI163 (14.6)108 (13.7)55 (16.9)0.16
Procedural specifications
 Post-TAVR AR moderate or severe103 (9.3)75 (9.5)28 (8.7)0.73
 Post-TAVR need for PPM within 30 days232 (20.8)157 (19.8)75 (23.1)0.26
 Valve in series20 (1.8)13 (1.6)7 (2.2)0.62

Values are mean ± SD or n (%).

AR = aortic regurgitation; PCI = percutaneous coronary intervention; PPM = permanent pacemaker implantation; TAVR = transcatheter aortic valve replacement.

  • Post-TAVR, or if missing, before discharge.